ClinicalTrials.Veeva

Menu

Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Completed

Conditions

Stimulant Abuse
HIV Prevention
Substance Abuse

Treatments

Behavioral: Standard of Care
Behavioral: IMPACT

Study type

Interventional

Funder types

Other

Identifiers

NCT03175159
1R01DA042805-01A1

Details and patient eligibility

About

This study seeks primarily to test, in a two-arm randomized controlled trial (RCT), the efficacy of Project IMPACT, an intervention that integrates Behavioral Activation (BA) with HIV risk reduction (RR) counseling for HIV-uninfected men who have sex with men (MSM) with stimulant use disorder at risk for HIV via sexual behavior. HIV-uninfected MSM with a diagnosis of stimulant use disorder will be equally randomized to one of two study arms: (1) the Project IMPACT intervention, BA-RR counseling, which lasts ten sessions; and (2) the standard of care (SOC) comparison condition, including two equivalent sexual risk-reduction counseling sessions. Participants will be followed for one year post-randomization, with assessments at months four, eight, and 12.

Full description

Project IMPACT targets both stimulant use and sexual risk reduction in effort to help individuals relearn how to enjoy safe but pleasurable activities. The intervention integrates BA, an evidence-based cognitive behavior therapy for improving mood and increasing activity, incorporated with RR counseling aimed to reduce risky sexual practices, and potential HIV acquisition. This RCT is a two-arm efficacy trial, comparing the Project IMPACT Intervention with a SOC arm. All participants will receive HIV testing, pre-/post-test risk reduction counseling, oral swab toxicology test at baseline and 12 months, assessment of interest/indication for Pre-Exposure Prophylaxis (PrEP) per Center for Disease Control guidelines, and active referral to local PrEP services as standard-of-care. Finally, the RCT will integrate resource utilization and cost-effectiveness analyses to examine cost efficiency of the Project IMPACT Intervention as a component of data analysis.

Enrollment

205 patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 or older
  • Assigned male at birth
  • HIV-uninfected verified via rapid HIV test
  • Self-reports in the past four months: CAS receptive or insertive with a cisgender male sexual partner, while using stimulants and without the protection of Pre-Exposure Prophylaxis (PrEP)*
  • Able to read, speak, and understand English
  • Willing and able to provide informed consent

Exclusion criteria

  • Does not live in the greater Boston or Miami areas, or will move away from Boston or Miami within the next 12 months
  • Self-reports being 100% adherent to PrEP in the last four months
  • Unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of interview
  • Discovery of active suicidal ideation at the time of interview (participants will be referred immediately for treatment, but may join the study once resolved)-
  • Involvement in any other HIV Prevention study that may interfere with the ability to test major study outcomes (e.g. another sexual risk reduction intervention or PrEP adherence intervention)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

205 participants in 2 patient groups

Standard of Care (SOC)
Active Comparator group
Description:
Sexual risk-reduction counseling sessions.
Treatment:
Behavioral: Standard of Care
Behavioral Activation & Risk Reduction Counseling
Experimental group
Description:
Behavioral activation with risk reduction counseling.
Treatment:
Behavioral: IMPACT

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Steve Safren, PhD; Matthew J Mimiaga, ScD, MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems